The International Prognostic Index Is Associated with Outcomes in Diffuse Large B Cell Lymphoma after Chimeric Antigen Receptor T Cell Therapy
Marta García‐Recio, Kitsada Wudhikarn, Martina Pennisi, Rosalía Alonso, Jessica Flynn, Roni Shouval, Aishat Olaide Afuye, Mari Lynne Silverberg, Connie Lee Batlevi, Parastoo B. Dahi, Sean M. Devlin, Sergio Giralt, Elizabeth Halton, Josel D. Ruiz, Molly Maloy, Elena Mead, M. Lia Palomba, Bianca Santomasso, Craig S. Sauter, Michael Scordo, Gunjan L. Shah, Miguel‐Angel Perales
Topics & Concepts
International Prognostic IndexMedicineDiffuse large B-cell lymphomaOncologyInternal medicineChimeric antigen receptorCytokine release syndromeHematopoietic stem cell transplantationRituximabLymphomaTransplantationCancerImmunotherapyCAR-T cell therapy researchIntegrated Circuits and Semiconductor Failure AnalysisAdvancements in Semiconductor Devices and Circuit Design